Page 59 - Sohini Das

M&As to drive hospital expansion in uncharted territory, say experts

Inorganic expansion gives instant market share in a new geography, greenfield works better in markets where a chain already has a presence, say industry players and analysts

Suven starts Phase 3 trial for first home-grown Alzheimer's drug

Clinical trial randomisation is the process of assigning patients by chance to groups that receive different treatments

Do you still need to wear a mask? Here's what doctors have to say

Doctors say that most people have some form of immunity against the virus already

How did IHH Healthcare manage to nurse Fortis hospitals back to health

After a bruising bidding war four years ago, Fortis has moved to pare its debt and expand modestly

Trying to lock in vendors who don't want to buy from China: Biocon CEO & MD

Siddharth Mittal, CEO & MD, Biocon, elaborates on his plans to grow this business further

Hospitals see influx of foreign patients in Sept qtr as travel norms ease

Several corporate hospitals say international patient footfalls have crossed pre-pandemic levels

Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%

Biocon's core Ebitda came in at Rs 816 crore, up 34 per cent

India' health sector got $1.5-billion investment so far this year

Investment activity in the health care space has not slowed down due to the Covid-19 pandemic

Govt, pharma companies working on pricing mechanism for off-patent drugs

Experts say this will create a predictable pricing regime for both the consumer and manufacturer

Fortis Healthcare sees strong growth in hospital revenues in Q2FY23

Q2FY23 hospital business revenues stood at Rs 1,297 crore versus Rs 1,098.5 crore in Q2FY22 and Rs 1,192.4 crore in Q1FY23

Time has passed when offer price of Rs 170 for a share was good: IHH's Loh

Will start rebranding Fortis as Parkway shortly: Fortis chairman Ravi Rajagopal

Sun Pharma's Mohali plant in Punjab receives OAI status from USFDA

The plant was inspected in August and had received a form 483 with six observations earlier

INSACOG finds new ways for Covid-19 sampling amid a low case count

Plans afoot to expand INSACOG to South Asian countries

Viatris eyes $1 billion revenue from eye care acquisitions by 2028

Company has bought ophthalmology business of Taparia family-backed Famy Life Sciences

India's cancer treatment infra in rapid expansion mode as cases soar

Capacity build-up via hub-and-spoke route; experts say country would need 10,000-15,000 more day-care beds and 25,000 surgical beds if all reported patients are to avail treatment

Cipla Q2 PAT up 11% PAT to Rs 789 cr on strong Covid-adjusted growth rate

The company is de-risking key product Abraxane in case the Goa plant FDA issue is not cleared immediately

Pharma marketing practices: High-level committee to meet industry on Friday

The UCPMP is voluntary and there is no legal penalty for violating the code

Parliamentary panel recommends setting up regulators for medical devices

The Parliamentary Standing Committee on Health and Family Welfare has recommended setting up of a new set of regulators at different levels for regulating the medical Devices industry

We thrive on products that have limited competition: Top Sun Pharma execs

In a Q&A, the firm's US business head and its group CFO talk about their plans to scale the specialty products business further, and dwell on the company's strategies post-pandemic

Janaushadhi stores for affordable medicines grew 100-times in 8 yrs: Govt

More than Rs 15,360 crore estimated to have been saved due to central government service